Mathieu Baconnier

643 total citations
15 papers, 130 citations indexed

About

Mathieu Baconnier is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Mathieu Baconnier has authored 15 papers receiving a total of 130 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 3 papers in Epidemiology. Recurrent topics in Mathieu Baconnier's work include Colorectal Cancer Treatments and Studies (8 papers), Gastric Cancer Management and Outcomes (5 papers) and Pancreatic and Hepatic Oncology Research (3 papers). Mathieu Baconnier is often cited by papers focused on Colorectal Cancer Treatments and Studies (8 papers), Gastric Cancer Management and Outcomes (5 papers) and Pancreatic and Hepatic Oncology Research (3 papers). Mathieu Baconnier collaborates with scholars based in France and India. Mathieu Baconnier's co-authors include Olivier Bouché, Roger Faroux, Laurent Bedenne, Thomas Aparicio, F. Khemissa Akouz, Éric François, Farid El Hajbi, Éléna Paillaud, Karine Le Malicot and Yves Rinaldi and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Cancers.

In The Last Decade

Mathieu Baconnier

15 papers receiving 128 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mathieu Baconnier France 6 106 45 29 20 15 15 130
Oana Cojocarasu France 6 94 0.9× 45 1.0× 14 0.5× 12 0.6× 7 0.5× 15 135
Bruce Colwell Canada 8 145 1.4× 37 0.8× 34 1.2× 18 0.9× 13 0.9× 17 180
Tomohiro Ozaki Japan 9 127 1.2× 117 2.6× 13 0.4× 24 1.2× 12 0.8× 19 188
Irene Pecora Italy 9 130 1.2× 99 2.2× 20 0.7× 32 1.6× 18 1.2× 24 207
Cristina Morelli Italy 8 125 1.2× 53 1.2× 42 1.4× 37 1.9× 5 0.3× 23 201
Lionel Uwer France 6 140 1.3× 56 1.2× 8 0.3× 38 1.9× 4 0.3× 14 189
Alana Little Australia 8 98 0.9× 42 0.9× 14 0.5× 28 1.4× 10 0.7× 11 183
Mario Domenico Rizzato Italy 8 48 0.5× 29 0.6× 31 1.1× 29 1.4× 40 2.7× 24 120
Fumimasa Kitamura Japan 8 65 0.6× 25 0.6× 6 0.2× 20 1.0× 17 1.1× 16 132
David W.G. ten Cate Netherlands 7 66 0.6× 42 0.9× 10 0.3× 15 0.8× 50 3.3× 16 157

Countries citing papers authored by Mathieu Baconnier

Since Specialization
Citations

This map shows the geographic impact of Mathieu Baconnier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathieu Baconnier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathieu Baconnier more than expected).

Fields of papers citing papers by Mathieu Baconnier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mathieu Baconnier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathieu Baconnier. The network helps show where Mathieu Baconnier may publish in the future.

Co-authorship network of co-authors of Mathieu Baconnier

This figure shows the co-authorship network connecting the top 25 collaborators of Mathieu Baconnier. A scholar is included among the top collaborators of Mathieu Baconnier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mathieu Baconnier. Mathieu Baconnier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Bouhier‐Leporrier, Karine, et al.. (2024). Relative dose intensity of first-line triplet chemotherapy in metastatic colorectal cancer. Digestive and Liver Disease. 57(1). 30–37. 2 indexed citations
2.
3.
Roth, Gaël S., Yohan Fayet, Françoise Ducimetière, et al.. (2022). Structural and Socio-Spatial Determinants Influencing Care and Survival of Patients with a Pancreatic Adenocarcinoma: Results of the PANDAURA Cohort. Cancers. 14(21). 5413–5413. 1 indexed citations
4.
Legoux, Jean-Louis, Roger Faroux, Nicolas M. Barrière, et al.. (2022). Aflibercept-LV5FU2 as first-line treatment of non-resectable metastatic colorectal cancers: Results of the FOLFA randomized phase II trial.. Journal of Clinical Oncology. 40(16_suppl). 3555–3555. 1 indexed citations
5.
Lepage, Côme, Jean–Marc Phelip, Laurent Cany, et al.. (2020). 398O Effect of 5 years of imaging and CEA follow-up to detect recurrence of colorectal cancer (CRC) - PRODIGE 13 a FFCD phase III trial. Annals of Oncology. 31. S410–S410. 5 indexed citations
6.
Legoux, Jean-Louis, Roger Faroux, Nicolas M. Barrière, et al.. (2020). 444P PRODIGE 25 (FFCD 11-01)-FOLFA: A randomized phase II trial evaluating aflibercept associated with LV5FU2 regimen as first-line treatment of non-resectable metastatic colorectal cancers. Annals of Oncology. 31. S430–S431. 1 indexed citations
7.
Limagne, Emeric, Marion Thibaudin, Julie Blanc, et al.. (2020). Baseline Splenic Volume as a Prognostic Biomarker of FOLFIRI Efficacy and a Surrogate Marker of MDSC Accumulation in Metastatic Colorectal Carcinoma. Cancers. 12(6). 1429–1429. 12 indexed citations
8.
Aparicio, Thomas, Olivier Bouché, Julien Taı̈eb, et al.. (2017). Bevacizumab+chemotherapy versus chemotherapy alone in elderly patients with untreated metastatic colorectal cancer: a randomized phase II trial—PRODIGE 20 study results. Annals of Oncology. 29(1). 133–138. 50 indexed citations
9.
Aparicio, Thomas, O. Bouché, Éric François, et al.. (2016). Prognostic factor analysis for elderly patients treated for metastatic colorectal cancer in the randomized phase II trial PRODIGE 20. Annals of Oncology. 27. vi194–vi194. 1 indexed citations
10.
Lepage, Côme, Jean–Marc Phelip, Laurent Cany, et al.. (2015). Effect of 5 years of imaging and CEA follow-up to detect recurrence of colorectal cancer: The FFCD PRODIGE 13 randomised phase III trial. Digestive and Liver Disease. 47(7). 529–531. 28 indexed citations
11.
Aparicio, Thomas, Olivier Bouché, Éric François, et al.. (2015). PRODIGE 20: Bevacizumab + chemotherapy (BEV-CT) versus chemotherapy alone (CT) in elderly patients (pts) with untreated metastatic colorectal cancer (mCRC)—A randomized phase II trial.. Journal of Clinical Oncology. 33(15_suppl). 3541–3541. 6 indexed citations
12.
Mariette, C., Guillaume Piessen, Denis Pezet, et al.. (2015). Efficacy and safety of perioperative chemotherapy with 5FU-cisplatine-cetuximab in gastric and gastroesophageal junction adenocarcinomas (GGOJA): A single-arm multicenter phase II trial (FFCD 0901).. Journal of Clinical Oncology. 33(3_suppl). 154–154. 4 indexed citations
13.
14.
Phelip, Jean–Marc, Mathieu Baconnier, Gabriele Barabino, et al.. (2011). Comparison of adiponectin concentration between pancreatic cancer and colorectal cancer.. PubMed. 2(4). 232–9. 8 indexed citations
15.
Baconnier, Mathieu, et al.. (2009). Trabectedin for the management of soft-tissue sarcoma. Expert Review of Anticancer Therapy. 9(6). 727–737. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Oana Cojocarasu Breakdown of academic impact, for papers by Bruce Colwell Breakdown of academic impact, for papers by Tomohiro Ozaki Breakdown of academic impact, for papers by Irene Pecora Breakdown of academic impact, for papers by Cristina Morelli Breakdown of academic impact, for papers by Lionel Uwer Breakdown of academic impact, for papers by Alana Little Breakdown of academic impact, for papers by Mario Domenico Rizzato Breakdown of academic impact, for papers by Fumimasa Kitamura Breakdown of academic impact, for papers by David W.G. ten Cate
Rankless by CCL
2026